Lovastatin Combination Therapy Increases the Survival and Proliferation of Rat Bone Marrow-Derived Mesenchymal Stem Cells Against the Inflammatory Activity of Lipopolysaccharide

Overview

Journal Cell Biochem Biophys

Specialties Biochemistry
Biophysics
Cell Biology

Date 2024 Jul 4

PMID 38963603

Authors

Ziba Khosravi

Leila Mirzaeian

Mohammad Taghi Ghorbanian

Farzaneh Rostami

Affiliations

Soon will be listed here.

Abstract

Oxidative stress hurts the survival of transplanted mesenchymal stem cells (MSCs). Lipopolysaccharide (LPS) preconditioning inhibits apoptotic death in MSCs. Also, Lovastatin's protective effect was reported on MSCs. Here, we investigated the potential of LPS and Lovastatin combination therapy on the survival and proliferation of MSCs. MSCs harvested from adult rats (240-260 g) femur and tibia bone marrow. Third passage MSCs were divided into 6 groups control group, LPS, LPS + Lovastatin (10 and 15 µM), and Lovastatin (10 and 15 µM). Cell survival and proliferation were assessed using an MTT assay 24 h after LPS, Lovastatin, or LPS + Lovastatin treatment. Also, Malondialdehyde (MDA) as a lipid peroxidation marker and antioxidant enzymes such as Glutathione peroxidase (GPX) and Superoxide dismutase (SOD) activity levels evaluated. Finally, the expression level of tumor protein P53 (P53) and octamer-binding transcription factor 4 (OCT4) genes were measured by qRT-PCR test. Lovastatin 10 μM potentiated proliferation and survival of MSCs. It can increase the activity of GPX and SOD. 10 µM Lovastatin could not affect MDA amounts but decreased the expression levels of P53 and Oct4 significantly. Nevertheless, treatment with LPS reduced the survival and proliferation of MSCs, along with a significant reduction in GPX activity. LPS + Lovastatin could increase SOD activity, however, GPX enzyme activity and MSCs proliferation did not change so, and it was not effective. We propose Lovastatin at the dose of 10 µM as a suitable combination agent to increase the survival and proliferation of MSCs in oxidative stress conditions.

References

Volkman R, Offen D . Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases. Stem Cells. 2017; 35(8):1867-1880. DOI: 10.1002/stem.2651. View

Ghorbanian M, Mirzaeian L, Taghi Ghorbanian M, Rostami F . Selegiline Differentiates Adult Stem Cells toward Dopaminergic-Like Neurons: A Comparison between Two Cellular Niches of Hippocampal Neurogenesis. Cell J. 2023; 25(6):383-390. PMC: 10331442. DOI: 10.22074/cellj.2023.1987841.1214. View

Hamedi H, Ghorbanian S, Mirzaeian L, Abrari K, Mozdziak P, Taghi Ghorbanian M . Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson's Disease. Cell J. 2023; 25(5):317-326. PMC: 10257054. DOI: 10.22074/cellj.2023.1972266.1161. View

Sarabadani M, Tavana S, Mirzaeian L, Fathi R . Co-culture with peritoneum mesothelial stem cells supports the in vitro growth of mouse ovarian follicles. J Biomed Mater Res A. 2021; 109(12):2685-2694. DOI: 10.1002/jbm.a.37260. View

Wang F, Wang Z, Zhang Y, Du Z, Zhang X, Liu Q . Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro. J Cell Biochem. 2013; 114(10):2346-55. DOI: 10.1002/jcb.24582. View

Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, Cohen S . Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood. 2006; 109(4):1422-32. DOI: 10.1182/blood-2006-06-028704. View

Rostami F, Oryan S, Ahmadiani A, Dargahi L . Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit. J Mol Neurosci. 2012; 48(1):22-34. DOI: 10.1007/s12031-012-9726-4. View

Qureshi S, Lariviere L, Leveque G, Clermont S, Moore K, Gros P . Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med. 1999; 189(4):615-25. PMC: 2192941. DOI: 10.1084/jem.189.4.615. View

Wang Z, Zhang F, Wang L, Yao Y, Zhao Q, Gao X . Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biol Int. 2009; 33(6):665-74. DOI: 10.1016/j.cellbi.2009.03.006. View

10.

Fakheri F, Abdanipour A, Parivar K, Jafari Anarkooli I, Rastegar H . Lovastatin alters neurotrophin expression in rat hippocampus‑derived neural stem cells in vitro. Acta Neurobiol Exp (Wars). 2019; 79(4):413-420. View

11.

Chen S, Liao M, Li J, Peng H, Xiong M . The correlation between microvessel pathological changes of the endplate and degeneration of the intervertebral disc in diabetic rats. Exp Ther Med. 2020; 20(5):1. PMC: 7475642. DOI: 10.3892/etm.2020.9129. View

12.

Taghi G, Ghasem Kashani Maryam H, Taghi L, Leili H, Leyla M . Characterization of in vitro cultured bone marrow and adipose tissue-derived mesenchymal stem cells and their ability to express neurotrophic factors. Cell Biol Int. 2012; 36(12):1239-49. DOI: 10.1042/CBI20110618. View

13.

Bagheri Y, Barati A, Nouraei S, Namini N, Bakhshi M, Fathi E . Comparative study of gavage and intraperitoneal administration of gamma-oryzanol in alleviation/attenuation in a rat animal model of renal ischemia/reperfusion-induced injury. Iran J Basic Med Sci. 2021; 24(2):175-183. PMC: 8061328. DOI: 10.22038/IJBMS.2020.51276.11642. View

14.

Bahrehbar K, Gholami S, Nazari Z, Malakhond M . Embryonic stem cells-derived mesenchymal stem cells do not differentiate into ovarian cells but improve ovarian function in POF mice. Biochem Biophys Res Commun. 2022; 635:92-98. DOI: 10.1016/j.bbrc.2022.10.014. View

15.

Rasouliyan F, Eskandani M, Jaymand M, Akbari Nakhjavani S, Farahzadi R, Vandghanooni S . Preparation, physicochemical characterization, and anti-proliferative properties of Lawsone-loaded solid lipid nanoparticles. Chem Phys Lipids. 2021; 239:105123. DOI: 10.1016/j.chemphyslip.2021.105123. View

16.

Kong D, Liu Q, Xu G, Huang Z, Luo N, Huang Y . Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia. Neurosci Lett. 2016; 637:175-181. DOI: 10.1016/j.neulet.2016.11.024. View

17.

Zhang Q, Chen Z, Zhao Y, Liu B, Liu N, Ke C . Bone Marrow Stromal Cells Combined With Sodium Ferulate and -Butylidenephthalide Promote the Effect of Therapeutic Angiogenesis via Advancing Astrocyte-Derived Trophic Factors After Ischemic Stroke. Cell Transplant. 2016; 26(2):229-242. PMC: 5657770. DOI: 10.3727/096368916X693536. View

18.

Wajid N, Mehmood A, Bhatti F, Khan S, Riazuddin S . Lovastatin protects chondrocytes derived from Wharton's jelly of human cord against hydrogen-peroxide-induced in vitro injury. Cell Tissue Res. 2012; 351(3):433-43. DOI: 10.1007/s00441-012-1540-3. View

19.

Zanin V, Marcuzzi A, Kleiner G, Piscianz E, Monasta L, Zacchigna S . Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo. J Cardiovasc Transl Res. 2013; 6(6):981-8. PMC: 3838599. DOI: 10.1007/s12265-013-9506-8. View

20.

He X, Wang H, Jin T, Xu Y, Mei L, Yang J . TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling. PLoS One. 2016; 11(3):e0149876. PMC: 4773221. DOI: 10.1371/journal.pone.0149876. View